[Adults with cystic fibrosis. It's not just about longevity]

H von der Hardt1, C Schwarz, G Ullrich

  • 1ehem. Medizinische Hochschule Hannover, Hannover, Deutschland.

Insights

Medical advances have significantly increased lifespan for individuals with cystic fibrosis (CF). However, this improved longevity brings challenges like long-term complications and treatment burdens, impacting quality of life.

Area of Science:

  • Pulmonology and Genetic Medicine
  • Chronic Disease Management

Context:

  • Cystic Fibrosis (CF) management has evolved, shifting from a childhood disease to a chronic condition impacting adults.
  • Since 2009, adults constitute the majority of CF patients in the German registry, highlighting increased longevity.
  • Improved survival rates present new challenges, including long-term complications and treatment burdens.

Purpose:

  • To discuss the evolving landscape of Cystic Fibrosis care.
  • To address the long-term complications and treatment burdens associated with increased patient longevity.
  • To emphasize the psychosocial aspects of prolonged life for CF patients.

Summary:

  • Medical progress has dramatically improved longevity in Cystic Fibrosis patients.
  • Long-term complications such as CF-related diabetes (CFRD) and osteoporosis are increasingly prevalent.
  • The cumulative effects of decades-long treatments and the psychosocial impact of living longer with CF require careful consideration.

Impact:

  • Highlights the need to balance treatment benefits against long-term side effects and burden.
  • Underscores the importance of addressing the psychosocial challenges of extended survival in CF.
  • Emphasizes that prolonged life in CF must be meaningful, not just longer.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...